{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:40:05Z","timestamp":1785516005996,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejon.2023.102322","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:33:34Z","timestamp":1678552414000},"page":"102322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-3733","authenticated-orcid":false,"given":"Natasha","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-9941","authenticated-orcid":false,"given":"Rosie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2023.102322_bib1","first-page":"e97","article-title":"Upper limb venous thromboembolism in early breast cancer patients on chemotherapy: a single centre experience","volume":"29","author":"Aravind","year":"2017","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejon.2023.102322_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5301\/jva.5000668","article-title":"Improving outcomes of short peripheral vascular access in oncology and chemotherapy administration","volume":"18","author":"Bertoglio","year":"2017","journal-title":"J. Vasc. Access"},{"key":"10.1016\/j.ejon.2023.102322_bib3","series-title":"Facts and Statistics 2021","year":"2021"},{"key":"10.1016\/j.ejon.2023.102322_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/fon-2018-0662","article-title":"Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective study","volume":"15","author":"Boccia","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejon.2023.102322_bib6","series-title":"UK Oncology Nursing Society (UKONS)","article-title":"Cancer therapy venous access device decision guide","author":"Flynn","year":"2014"},{"key":"10.1016\/j.ejon.2023.102322_bib7","first-page":"379","article-title":"Differential impact of fosaprepitant on infusion site adverse events between cisplatin-and anthracycline-based chemotherapy regimens","volume":"35","author":"Fujii","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejon.2023.102322_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1757177420976806","article-title":"UK vessel Health and preservation (VHP) framework: a commentary on the updated VHP 2020","volume":"22","author":"Hallam","year":"2021","journal-title":"J. Inf. Prev."},{"key":"10.1016\/j.ejon.2023.102322_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/jcm9030701","article-title":"The development and testing of a chemotherapy-induced phlebitis severity (CIPS) scale for patients receiving anthracycline chemotherapy for breast cancer","volume":"9","author":"Harris","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejon.2023.102322_bib12","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.12968\/bjon.2015.24.Sup14.S16","article-title":"Proactive placement of peripherally inserted central catheters","volume":"24","author":"Harrold","year":"2015","journal-title":"Br. J. Nurs."},{"key":"10.1016\/j.ejon.2023.102322_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/ijms.5.218","article-title":"Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits","volume":"5","author":"Kohno","year":"2008","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejon.2023.102322_bib14","author":"Lennan"},{"key":"10.1016\/j.ejon.2023.102322_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7748\/cnp.14.2.22.e1163","article-title":"Management of chemotherapy-related arm symptoms in patients with breast cancer","volume":"14","author":"Marshall-McKenna","year":"2015","journal-title":"Cancer Nurs. Pract."},{"key":"10.1016\/j.ejon.2023.102322_bib17","series-title":"Vessel Health and Preservation: the Right Approach for Vascular Access","author":"Moureau","year":"2019"},{"key":"10.1016\/j.ejon.2023.102322_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7748\/ns.36.11.70.s25","article-title":"Think superficial thrombophlebitis, because time might be of the essence","volume":"36","author":"O'Brien","year":"2021","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.ejon.2023.102322_bib20","first-page":"109","article-title":"Patient safety in the context of phlebitis reported in a university hospital","volume":"9","author":"Pereira","year":"2019","journal-title":"Revista de Epidemiologia e Controle de Infec\u00e7\u00e3o"},{"key":"10.1016\/j.ejon.2023.102322_bib21","article-title":"Epirubicin chemotherapy in women with breast cancer: alternating arms for intravenous administration to reduce chemical phlebitis","volume":"28","author":"Roberts","year":"2019","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.ejon.2023.102322_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clon.2020.11.025","article-title":"Identifying risk factors for anthracycline chemotherapy-induced phlebitis in women with breast cancer: an observational study","volume":"33","author":"Roberts","year":"2021","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejon.2023.102322_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1590\/S0103-21002012000300020","article-title":"Risk factors for vascular trauma during antineoplastic chemotherapy: contributions of the use of relative risk","volume":"25","author":"Rodrigues","year":"2012","journal-title":"Acta Paul. Enferm."},{"key":"10.1016\/j.ejon.2023.102322_bib24","doi-asserted-by":"crossref","DOI":"10.1590\/1980-220x-reeusp-2021-0398en","article-title":"Risk factors for peripheral intravenous catheter-related phlebitis in adult patients","volume":"56","author":"Sim\u00f5es","year":"2022","journal-title":"Rev. Esc. Enferm. USP"},{"key":"10.1016\/j.ejon.2023.102322_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s00268-013-2378-x","article-title":"Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage","volume":"38","author":"Singh","year":"2014","journal-title":"World J. Surg."},{"key":"10.1016\/j.ejon.2023.102322_bib26","series-title":"Pre-Procedural Considerations. The Royal Marsden Manual of Clinical and Cancer Nursing Procedures","year":"2020"},{"key":"10.1016\/j.ejon.2023.102322_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7748\/cnp.2020.e1692","article-title":"Offering breast cancer patients a choice of device for administration of chemotherapy: a service improvement project","volume":"19","author":"Thrush","year":"2020","journal-title":"Cancer Nurs. Pract."},{"key":"10.1016\/j.ejon.2023.102322_bib28","article-title":"An observational study of the effect of dilution and delivery speed on the development of phlebitis after epirubicin chemotherapy","volume":"21","author":"Wiltshire","year":"2019","journal-title":"Cancer Nurs. Pract."},{"key":"10.1016\/j.ejon.2023.102322_bib29","first-page":"1549","article-title":"Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention","volume":"20","author":"Yamada","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2023.102322_bib30","first-page":"43","article-title":"Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant","volume":"11","author":"Yamasaki","year":"2019","journal-title":"Molecular and Clinical Oncology"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146238892300056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146238892300056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:26:42Z","timestamp":1761424002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146238892300056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"alternative-id":["S146238892300056X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102322","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102322"}}